Differential Expression of miRNAs in Hypoxia ("HypoxamiRs") in Three Canine High-Grade Glioma Cell Lines.

cancer canine dog glioblastoma glioma hypoxia miRNA microRNA

Journal

Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658

Informations de publication

Date de publication:
2020
Historique:
received: 01 11 2019
accepted: 11 02 2020
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 8 4 2020
Statut: epublish

Résumé

Dogs with spontaneous high-grade gliomas increasingly are being proposed as useful large animal pre-clinical models for the human disease. Hypoxia is a critical microenvironmental condition that is common in both canine and human high-grade gliomas and drives increased angiogenesis, chemo- and radioresistance, and acquisition of a stem-like phenotype. Some of this effect is mediated by the hypoxia-induced expression of microRNAs, small (~22 nucleotides long), non-coding RNAs that can modulate gene expression through interference with mRNA translation. Using an

Identifiants

pubmed: 32258065
doi: 10.3389/fvets.2020.00104
pmc: PMC7093022
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104

Informations de copyright

Copyright © 2020 Koehler, Sandey, Prasad, Levy, Wang and Wang.

Références

Vet Comp Oncol. 2017 Mar;15(1):133-150
pubmed: 25808605
Nat Biotechnol. 2006 Sep;24(9):1065-6
pubmed: 16964204
J Exp Clin Cancer Res. 2014 Jan 19;33:9
pubmed: 24438238
Res Vet Sci. 2018 Apr;117:133-137
pubmed: 29272721
Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2541-50
pubmed: 27383303
J Neuropathol Exp Neurol. 2016 Jul;75(7):700-10
pubmed: 27251041
Anticancer Res. 2017 Dec;37(12):6511-6521
pubmed: 29187425
Biotechniques. 2002 Feb;32(2):432-4, 436, 438-40
pubmed: 11848419
Oncol Lett. 2016 Nov;12(5):4133-4138
pubmed: 27895782
Mol Cell Biochem. 2012 Nov;370(1-2):45-51
pubmed: 22833359
Clin Cancer Res. 2008 Mar 1;14(5):1340-8
pubmed: 18316553
PLoS One. 2011;6(5):e20600
pubmed: 21655185
Nature. 1999 May 20;399(6733):271-5
pubmed: 10353251
J Biol Chem. 2006 Jun 2;281(22):15215-26
pubmed: 16565084
Oncotarget. 2017 Feb 7;8(6):9899-9910
pubmed: 28038441
IUBMB Life. 2011 Feb;63(2):94-100
pubmed: 21360638
Clin Cancer Res. 2006 Oct 1;12(19):5698-704
pubmed: 17020973
Curr Mol Pharmacol. 2009 Nov;2(3):263-84
pubmed: 20021464
Int J Cancer. 2010 Jan 1;126(1):73-80
pubmed: 19551852
J Comp Pathol. 2016 Feb-Apr;154(2-3):169-79
pubmed: 26804204
Cell Mol Neurobiol. 2015 Jul;35(5):679-87
pubmed: 25662849
Cell Cycle. 2009 Oct 15;8(20):3274-84
pubmed: 19770585
J Biol Chem. 1996 Dec 13;271(50):32253-9
pubmed: 8943284
Neuro Oncol. 2016 Sep;18(9):1209-18
pubmed: 27179361
J Exp Clin Cancer Res. 2014 Jun 09;33:50
pubmed: 24909053
Vet Comp Oncol. 2018 Mar;16(1):102-107
pubmed: 28480569
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
J Biol Chem. 2001 Jan 19;276(3):2292-8
pubmed: 11056166
Gene. 2012 Oct 10;507(2):135-8
pubmed: 22842193
Mol Med Rep. 2017 Nov;16(5):6580-6589
pubmed: 28901452
Vet Comp Oncol. 2006 Sep;4(3):132-40
pubmed: 19754810
Mol Cell. 2008 May 23;30(4):393-402
pubmed: 18498744
J Clin Invest. 2010 Nov;120(11):3815-7
pubmed: 20972325
Biochim Biophys Acta Gene Regul Mech. 2017 Feb;1860(2):227-232
pubmed: 27923712
J Biol Chem. 2010 May 28;285(22):16854-63
pubmed: 20356845
J Neurooncol. 2010 May;98(1):49-55
pubmed: 19967449
Curr Pharm Biotechnol. 2014;15(9):839-46
pubmed: 25374033
Neuro Oncol. 2010 Sep;12(9):928-40
pubmed: 20488958
J Pathol. 2011 Jan;223(2):102-15
pubmed: 21125669
J Cancer. 2015 Jan 16;6(3):227-32
pubmed: 25663939
BMC Genomics. 2014 Aug 17;15:686
pubmed: 25129238
J Biol Chem. 2008 Jun 6;283(23):15878-83
pubmed: 18417479
Life Sci. 2019 Nov 15;237:116945
pubmed: 31605710
Biomaterials. 2016 Nov;107:74-87
pubmed: 27614160
Expert Opin Ther Targets. 2016 Nov;20(11):1325-1338
pubmed: 27359286
Cancer Lett. 2016 Sep 28;380(1):257-62
pubmed: 26523672
Onco Targets Ther. 2019 Apr 18;12:2999-3009
pubmed: 31114243
J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93
pubmed: 17971532
Mol Cancer Ther. 2008 Jan;7(1):59-70
pubmed: 18202010
Cancer. 2010 May 1;116(9):2148-58
pubmed: 20187102
J Biol Chem. 2009 Dec 11;284(50):35134-43
pubmed: 19826008
Folia Neuropathol. 2015;53(3):236-44
pubmed: 26443314
PLoS One. 2014 Feb 20;9(2):e89223
pubmed: 24586608
Nat Rev Cancer. 2008 Feb;8(2):147-56
pubmed: 18202698
Int J Clin Exp Pathol. 2015 Sep 01;8(9):10725-33
pubmed: 26617783
J Cell Biochem. 2019 Apr;120(4):5435-5443
pubmed: 30302807
Brain Pathol. 2010 May;20(3):539-50
pubmed: 19775293
J Neurooncol. 2007 Jan;81(2):123-9
pubmed: 16826366
Int J Mol Sci. 2015 Mar 19;16(3):6353-72
pubmed: 25809609
PLoS One. 2011;6(6):e20980
pubmed: 21738599
J Cancer. 2017 Aug 23;8(14):2854-2865
pubmed: 28928875
Nat Rev Cancer. 2008 Nov;8(11):865-73
pubmed: 18923434
Mol Ther Nucleic Acids. 2017 Dec 15;9:111-119
pubmed: 29246289
Mol Cell. 2010 Oct 22;40(2):294-309
pubmed: 20965423
Cell Physiol Biochem. 2015;36(4):1491-8
pubmed: 26160610
In Vitro Cell Dev Biol Anim. 1993 Apr;29A(4):310-8
pubmed: 8320182
Cell Death Differ. 2014 May;21(5):720-34
pubmed: 24440911
Cell Death Differ. 2012 Feb;19(2):284-94
pubmed: 21818118
Cell Biol Int. 2017 Dec;41(12):1272-1282
pubmed: 28225180
Cardiovasc Res. 2012 Mar 15;93(4):614-22
pubmed: 22135162
Transl Oncol. 2010 Jun 01;3(3):160-9
pubmed: 20563257
Neurochem Int. 2014 Nov;77:68-77
pubmed: 24937770
Free Radic Biol Med. 2013 Sep;64:20-30
pubmed: 23712003
Genome Biol. 2014 Jun 25;15(6):R83
pubmed: 24964909
Mol Neurobiol. 2014 Dec;50(3):896-913
pubmed: 24619503
Acta Neurochir (Wien). 1999;141(3):295-305; discussion 304-5
pubmed: 10214487
Trends Mol Med. 2010 May;16(5):230-7
pubmed: 20434954
J Neuropathol Exp Neurol. 2018 Nov 1;77(11):1039-1054
pubmed: 30239918
Biochim Biophys Acta. 2014 Mar;1843(3):508-16
pubmed: 24316134
Am J Physiol. 1998 Oct;275(4):L818-26
pubmed: 9755115
J Transl Med. 2013 Jan 09;11:10
pubmed: 23302469
Vet Comp Oncol. 2018 Jun;16(2):288-296
pubmed: 29314614
Oncol Rep. 2017 Sep;38(3):1751-1759
pubmed: 28731180
CNS Oncol. 2015;4(1):25-35
pubmed: 25586423
Trends Mol Med. 2006 Dec;12(12):580-7
pubmed: 17071139
Trends Mol Med. 2011 Jul;17(7):380-8
pubmed: 21439907
Oncol Rep. 2016 Jul;36(1):263-70
pubmed: 27121324
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Nucleic Acids Res. 2019 Jul 2;47(W1):W234-W241
pubmed: 30931480
Am J Vet Res. 2013 Jan;74(1):122-9
pubmed: 23270356
Vet Pathol. 2012 Sep;49(5):796-801
pubmed: 22002975
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13092-7
pubmed: 17670948
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Front Oncol. 2016 Jan 21;5:306
pubmed: 26835415
Nat Rev Cancer. 2006 Nov;6(11):857-66
pubmed: 17060945
Biomed Pharmacother. 2018 Jan;97:528-534
pubmed: 29091904
Neuro Oncol. 2013 Nov;15 Suppl 2:ii1-56
pubmed: 24137015
Int J Cancer. 2004 Mar 1;108(6):833-8
pubmed: 14712484
Exp Cell Res. 2012 Nov 15;318(19):2417-26
pubmed: 22906859
Neuro Oncol. 2015 May;17(5):652-62
pubmed: 25301812
Genome Biol. 2019 Jan 22;20(1):18
pubmed: 30670076
J Neurooncol. 2011 Dec;105(3):607-12
pubmed: 21710351
Gene Expr. 1998;7(3):205-13
pubmed: 9840812
Brain. 2010 Apr;133(Pt 4):983-95
pubmed: 20375133

Auteurs

Jennifer Koehler (J)

Department of Pathobiology, Auburn University, Auburn, AL, United States.

Maninder Sandey (M)

Department of Pathobiology, Auburn University, Auburn, AL, United States.

Nripesh Prasad (N)

HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.

Shawn A Levy (SA)

HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.

Xiaozhu Wang (X)

Department of Pathobiology, Auburn University, Auburn, AL, United States.

Xu Wang (X)

Department of Pathobiology, Auburn University, Auburn, AL, United States.
HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.
Alabama Agricultural Experimental Station, Auburn University, Auburn, AL, United States.

Classifications MeSH